RG
IONS icon

Retirement Group’s Ionis Pharmaceuticals IONS Stock Holding History

Retirement Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$477 Hold
11
– – ﹤0.01% 760
2023
Q4 		$556 Hold
11
– – ﹤0.01% 742
2023
Q3 		$499 Hold
11
– – ﹤0.01% 680
2023
Q2 		$451 Hold
11
– – ﹤0.01% 725
2023
Q1 		$0 Hold
11
– – ﹤0.01% 717
2022
Q4 		$0 Hold
11
– – ﹤0.01% 678
2022
Q3 		$0 Hold
11
– – ﹤0.01% 645
2022
Q2 		$0 Hold
11
– – ﹤0.01% 778
2022
Q1 		$0 Buy
+11
New +$360 ﹤0.01% 782

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Retirement Group's IONS Position: Q1 2024 in Review

Retirement Group held its Ionis Pharmaceuticals (IONS) position steady in Q1 2024 at 11 shares worth $477. The position accounts for ﹤0.01% of the portfolio, ranked #760.

Retirement Group first reported a position in IONS in Q1 2022 and has held it in 9 quarters since. The position peaked at $556 in Q4 2023. 361 funds tracked by Wall St. Rank hold IONS as of Q1 2024.

  • Retirement Group held 11 shares of Ionis Pharmaceuticals worth $477 as of Q1 2024.
  • Retirement Group left its Ionis Pharmaceuticals share count unchanged in Q1 2024.
  • Ionis Pharmaceuticals made up ﹤0.01% of Retirement Group's portfolio in Q1 2024, its #760 holding.
  • Retirement Group first reported a position in Ionis Pharmaceuticals in Q1 2022 and has held it in 9 quarters since.
  • Retirement Group's Ionis Pharmaceuticals position peaked at $556 in Q4 2023.
  • 361 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2024.

Based on Retirement Group's 13F filing for Q1 2024, filed 30 Apr 2024.